Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC-Reference-Cited by-同舟云学术

Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC

Published:2022-09 Issue:9 Volume:17 Page:1078-1085
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Fernandez Aileen I.,Gavrielatou Niki,McCann Leena,Shafi Saba,Moutafi Myrto K.,Martinez-Morilla Sandra,Vathiotis Ioannis A.,Aung Thazin Nwe,Yaghoobi Vesal,Bai Yalai,Chan Yvonne G.,Weidler Jodi,Herbst Roy,Bates Michael,Rimm David L.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference10 articles.

1. PD-1 and its ligands in tolerance and immunity;Keir;Annu Rev Immunol,2008

2. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

3. Immune checkpoint inhibitors of PD-L1 as cancer therapeutics;Akinleye;J Hematol Oncol,2019

4. Clinical characteristics and treatment of immune-related adverse events of immune checkpoint inhibitors;Choi;Immune Network,2020

5. Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma;Gupta;J Immunother Cancer,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade;Cell Biology and Toxicology;2024-07-23

2. Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancer;Clinical and Experimental Medicine;2024-07-18

3. Current status of molecular diagnostics for lung cancer;Exploration of Targeted Anti-tumor Therapy;2024-06-27

4. Plasma cell-free RNA PD-L1 or tissue PD-L1 protein expression and outcomes with first-line immunotherapy in metastatic non-small cell lung cancer;The Journal of Liquid Biopsy;2024-03

5. System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma;Computers in Biology and Medicine;2023-10